Resiliva (Resmetirom 80 mg Tablets)

Resiliva (Resmetiroom 80 mg Tablets) is an oral, liver-directed thyroid hormone receptor-β (THR-β) agonist, used as a part of significant treatment in patients with non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD). These ongoing liver diseases are frequently associated with metabolic problems such as obesity, insulin resistance, and dyslipidemia.

Resmetirom has developed as an innovative, targeted therapy toward reducing hepatic fat accumulation and improving dyslipidemia which has progression to fibrosis. This is achieved largely without off-target effects, particularly cardiac effects. Resiliva 80 mg will be a hopeful future saver for patients from developing liver cirrhosis or cardiovascular complications. This modern formulation is available right now from trusted suppliers like Onus Pharma with manufacturing quality guaranteed by Everest Pharmaceuticals Ltd., Bangladesh.

Therapeutic Applications

Resmetirom 80 mg tablet is a selective thyroid hormone receptor-bete (THR-β) agonist certainly used in patients with nonalcoholic steatohepatitis (NASH) liver fibrosis. It may work without affecting heart or other thyroid hormone-sensitive tissues and has been designed to reduce liver fat, inflammation, and fibrosis progression.

It also improves hepatic lipid metabolism, promotes fat oxidation, and decreases lipotoxicity by targeting liver specific routes. These features make it promising in therapeutic options NASH and liver cirrhosis treatment.

Administration and Dosage Guidelines

Nonalcoholic Steatohepatitis

Adult patients with non-cirrhotic non-alcoholic steatohepatitis (NASH) who have moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis)  should take this medication together with diet and exercise and the recommended dosage is based on actual body weight.

• If a patient is less than 100 kg, the recommended dose is 80 mg daily once by mouth.

• If a patient is equal or more than 100 kg, the recommended dose is 100 mg daily once by mouth.

Dosage Modifications

Dosage modification is dependent on the patient’s health condition, absorption of the medication and other relevant factors. If patients face any adverse side effects, instead of stopping treatment, consultation with their healthcare giver is a must.

Resiliva 80 mg is an Excellent Manufacturing indication of Everest Pharmaceutical

Everest Pharmaceuticals has shown their technical excellence in making Resiliva 80 mg. It was meticulously designed for liver fibrosis and liver directed thyroid disease treatment under certain conditions making it more clinically safe as a generic medicine. As a GMP certified pharmaceutical, they have maintained all the criteria, and ensure more safety with less side effects. It is more affordable and easily accessible for all the patients globally. 

Their commitment in innovation considers the patient’s safety, efficacy, affordability for everyone. 

Onus Pharma Helps in Global Accessibility

Onus Pharma, A name with trust, gives you the opportunity to access Resiliva (Resmetirom 80 mg tablets) globally. You can access this medication as a patient, healthcare provider and a  clinic. To access this medication globally you need 

• A valid prescription provided by a licensed healthcare provider. 
• Send us the prescription, our customer service executive will contact you.
• Get detailed information about price, delivery and availability.
• Onus pharma guarantees you timely and safe delivery at your doorstep.

Pricing and Access

Resiliva 80 mg price in Bangladesh is significantly lower than other brands of the same generic Resmetirom available globally. Especially in Asia, most of the population have less purchasing ability than western or European countries, this cost-effective treatment option is a blessing for them. Some countries like China, Singapore, Vietnam, Philippines, Thailand, and  Malaysia have a higher ratio of liver disease but not having the ability to purchase expensive medicine makes them suffer. 

Though the price may vary depending on location, and other factors Onus Pharma give you personalized access to this medication.

Related Medicines which are used to treat hepatitis and other viral diseases such as Daclaxen 60 mg, Nexataf 25 mg, Velpanex, Mavixen.

Disclaimer: This content provides only general information, it does not allow you to use this as any medical alternative advice. This information only reflects general information on the package body and all about the process of accessing the medication for patients and healthcare providers.